Immunomedics, a subsidiary of Gilead Sciences, is a leader in next generation antibody-drug
conjugate (ADC) technology, committed to helping people with hard-to-treat cancers.
Documents
Links
HCP Efficacy and Safety Brochure
Download File
Prescribing Information Booklet
Download File
TRODELVY Website
Open link in new window